Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar rockportfred (80.21) Submitted: 5/23/2011 11:24:18 AM : Outperform Start Price: $2.81 BPAX Score: -81.67

female sex stimuli

Featured Broker Partners


Advertisement